Association of gastrointestinal events with osteoporosis treatment initiation and treatment compliance in Germany: An observational study
Open Access
- 1 December 2016
- journal article
- Published by Elsevier in Bone Reports
- Vol. 5, 208-213
Abstract
No abstract availableKeywords
Funding Information
- Merck & Co., Inc.
This publication has 22 references indexed in Scilit:
- Osteoporosis in the European Union: medical management, epidemiology and economic burdenArchives of Osteoporosis, 2013
- Burden of postmenopausal osteoporosis in Germany: estimations from a disease modelArchives of Osteoporosis, 2012
- Persistence and compliance of medications used in the treatment of osteoporosis – analysis using a large scale, representative, longitudinal German databaseInt. Journal of Clinical Pharmacology and Therapeutics, 2012
- Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medicationsArchives of Osteoporosis, 2010
- Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USAOsteoporosis International, 2009
- Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti‐inflammatory drugs: a case‐control studyAlimentary Pharmacology & Therapeutics, 2009
- Fracture Outcomes Related to Persistence and Compliance With Oral BisphosphonatesJournal of Bone and Mineral Research, 2008
- The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal womenJournal of the American Academy of Nurse Practitioners, 2008
- Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fractureOsteoporosis International, 2006
- Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA StudyOsteoporosis International, 2006